Market Place
Sourcing Support
Korro Bio`s Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10 Apr 2026 //
GLOBENEWSWIRE
Korro Reports 2025 Financial Results And Corporate Update
12 Mar 2026 //
GLOBENEWSWIRE
Korro Announces Oversubscribed $85 Million Private Placement
09 Mar 2026 //
GLOBENEWSWIRE
Korro To Present At TD Cowen Health Care Conference
25 Feb 2026 //
GLOBENEWSWIRE
Korro To Host Virtual Analyst Day On January 27, 2026
20 Jan 2026 //
GLOBENEWSWIRE
JPM26: Korro Bio Looks To Save Itself Despite Unenviable Position
16 Jan 2026 //
BIOSPACE
Korro To Present At J.P. Morgan Healthcare Conference
08 Jan 2026 //
GLOBENEWSWIRE
Korro Lays Off Staff As Lead Drug Disappoints, Novo Pauses Pact
13 Nov 2025 //
FIERCE BIOTECH
Korro Updates Q3 Financials, Progress On KRRO-110
12 Nov 2025 //
GLOBENEWSWIRE
Korro`s Q2 2025 Financial Results and Business Updates
12 Aug 2025 //
GLOBENEWSWIRE
Korro lays off 20% to fund genetic med trials, Novo collab
08 May 2025 //
FIERCE BIOTECH
Korro Reports Q1 2025 Financial Results and Business Updates
07 May 2025 //
GLOBENEWSWIRE
Korro Appoints LoIc Vincent, Ph.D., as Chief Scientific Officer
01 Apr 2025 //
GLOBENEWSWIRE
Korro Bio Doses 1st In Rewrite Study For A1AT Deficiency
13 Jan 2025 //
GLOBENEWSWIRE
Korro to Present at the 43rd Annual J.P. Morgan Conference
07 Jan 2025 //
GLOBENEWSWIRE
Korro`s Approval to Ph 1/2a Study of Alpha-1 Antitrypsin Deficiency
21 Nov 2024 //
GLOBENEWSWIRE
Korro to Present at the Jefferies London Healthcare Conference
14 Nov 2024 //
GLOBENEWSWIRE
Korro Files for KRRO-110 First-In-Human Study, Forms Advisory Board
04 Nov 2024 //
GLOBENEWSWIRE
Korro Presents At Oligonucleotide Therapeutics Society Meeting
30 Sep 2024 //
GLOBENEWSWIRE
Novo Nordisk`s latest RNA deal involves $530M biobucks to sing in Korro`s opera
17 Sep 2024 //
FIERCE BIOTECH
Korro to Participate in Upcoming Investor Conferences
10 Sep 2024 //
GLOBENEWSWIRE
Korro Announces Board Changes: Knobil Joins, Lucchino Resigns
28 Aug 2024 //
GLOBENEWSWIRE
Korro to Participate in Upcoming September Investor and Scientific Conferences
27 Aug 2024 //
GLOBENEWSWIRE
Korro Reports Q2 2024 Results And Provides Business Updates
13 Aug 2024 //
GLOBENEWSWIRE
Korro Presents Additional KRRO-110 Preclinical Data At ATS 2024
20 May 2024 //
GLOBENEWSWIRE
Korro Announces Selection of its First Development Candidate for AATD
07 Dec 2023 //
GLOBENEWSWIRE
Korro Bio, Genevant to Develop RNA Editing Therapeutic
07 Mar 2023 //
CONTRACT PHARMA
